Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Insignis Therapeutics announced it raised $6 Million in an initial filing from an offering of $8.5 Million
PRIVATEAug 05, 2026•4 days ago
Amount Raised
$6 Million
Round Type
Venture - Series Unknown
North HavenOther
Company Information
Company
Insignis Therapeutics
Location
410 SACKETT POINT ROAD
North Haven, Connecticut, United States
About
Our Drug Development Model
To advance our promising drug candidates as quickly as possible toward regulatory approval, Insignis works with carefully selected strategic partners to leverage their complementary resources and drug development expertise and industry leading CDMOs for API and drug product development and manufacture. This drug development model enables us to achieve record speed in reaching key drug development milestones (INDs and NDAs).
Predictive Intelligence
Strategic
ML-powered predictions for Insignis Therapeutics's next move
North Haven